Publications by authors named "Charles Pally"

8Publications

An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation.

Authors:
Daniela Angst Philipp Janser Jean Quancard Peter Buehlmayer Frederic Berst Lukas Oberer Christian Beerli Markus Streiff Charles Pally Rene Hersperger Christian Bruns Frederic Bassilana Birgit Bollbuck

J Med Chem 2012 Nov 26;55(22):9722-34. Epub 2012 Oct 26.

Novartis Pharma AG, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
November 2012

Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.

Authors:
Gisbert Weckbecker Charles Pally Christian Beerli Christoph Burkhart Grazyna Wieczorek Barbara Metzler Randall E Morris Juergen Wagner Christian Bruns

Transpl Int 2010 May 9;23(5):543-52. Epub 2009 Dec 9.

Novartis Institutes for BioMedical Research, Autoimmunity and Transplantation Disease Area, Novartis Pharma AG, Basel, Switzerland.

View Article and Find Full Text PDF
May 2010

Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.

Authors:
Klemens Högenauer Andreas Billich Charles Pally Markus Streiff Trixie Wagner Karl Welzenbach Peter Nussbaumer

ChemMedChem 2008 Jul;3(7):1027-9

Novartis Institutes for Biomedical Research, Brunner Strasse 59, 1235 Wien, Austria.

View Article and Find Full Text PDF
July 2008

A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model.

Authors:
Shifeng Pan Yuan Mi Charles Pally Christian Beerli Alice Chen Danilo Guerini Klaus Hinterding Barbara Nuesslein-Hildesheim Tove Tuntland Sophie Lefebvre Yi Liu Wenqi Gao Alan Chu Volker Brinkmann Christian Bruns Markus Streiff Catherine Cannet Nigel Cooke Nathanael Gray

Chem Biol 2006 Nov;13(11):1227-34

Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, USA.

View Article and Find Full Text PDF
November 2006

Macrophage infiltration detected at MR imaging in rat kidney allografts: early marker of chronic rejection?

Authors:
Nicolau Beckmann Catherine Cannet Stefan Zurbruegg Reto Haberthür Jianping Li Charles Pally Christian Bruns

Radiology 2006 Sep 12;240(3):717-24. Epub 2006 Jul 12.

Departments of Discovery Technologies and Transplantation Research, Novartis Institutes for BioMedical Research, Lichtstrasse 35, WSJ-386.2.09, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
September 2006

Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection.

Authors:
Hans Voshol Nathalie Brendlen Dieter Müller Bruno Inverardi Angélique Augustin Charles Pally Grazyna Wieczorek Randall E Morris Friedrich Raulf Jan van Oostrum

J Proteome Res 2005 Jul-Aug;4(4):1192-9

Novartis Institutes for BioMedical Research, Genome and Proteome Sciences and Transplantation & Immunology Therapeutic Area, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
October 2005

Transplantation-induced functional/morphological changes in rat aorta allografts differ from those in arteries of rat kidney allografts.

Authors:
Emile Andriambeloson Catherine Cannet Charles Pally Bernd Klanke Christian Bruns Hans-Günter Zerwes Marc Bigaud

Am J Transplant 2004 Feb;4(2):188-95

Novartis Pharma AG, Transplantation Research Global Business Unit, Basel, Switzerland.

View Article and Find Full Text PDF
February 2004

Mycophenolate sodium: tolerability and efficacy in transplantation in the rat.

Authors:
Henk-Jan Schuurman Madeleine Fringeli-Tanner Charles Pally Christos Papageorgiou

Transpl Immunol 2002 May;9(2-4):187-95

Transplantation Research, Novartis Pharma AG, Basel, Switzerland.

View Article and Find Full Text PDF
May 2002